Candriam S.C.A. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,099,000
-67.8%
45,000
-79.1%
0.01%
-68.4%
Q1 2020$3,411,000
-2.2%
215,0000.0%0.04%
+2.7%
Q4 2019$3,489,000
+13.2%
215,000
-9.3%
0.04%
-9.8%
Q3 2019$3,081,000
+0.7%
237,0000.0%0.04%
+7.9%
Q2 2019$3,060,000
-18.1%
237,0000.0%0.04%
-20.8%
Q1 2019$3,735,000
-21.7%
237,0000.0%0.05%
-34.2%
Q4 2018$4,771,000
+12.3%
237,000
+38.6%
0.07%
+30.4%
Q3 2018$4,249,000
-9.5%
171,0000.0%0.06%
-24.3%
Q2 2018$4,694,000
-10.9%
171,0000.0%0.07%
-17.8%
Q1 2018$5,267,000
-2.4%
171,000
+13.2%
0.09%
-3.2%
Q4 2017$5,398,000
+44.1%
151,000
+11.0%
0.09%
+43.1%
Q3 2017$3,747,000
+1.4%
136,000
-2.9%
0.06%
-5.8%
Q2 2017$3,696,000
+45.6%
140,000
+14.8%
0.07%
+40.8%
Q1 2017$2,538,000
+83.0%
122,000
+82.1%
0.05%
+53.1%
Q4 2016$1,387,00067,0000.03%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders